|
2026
|
Invention
|
Antibodies that bind a conformation-specific epitope of tau protein. The invention concerns isola... |
|
|
Invention
|
Means and method for identifying genetic alterations contributing to a complex trait. The inventi... |
|
|
Invention
|
Combination therapy with cd13-targeted chimeric proteins or chimeric protein complexes.
The pres... |
|
|
Invention
|
Combination therapy. The invention provides inter alia a method of treating cancer in a subject c... |
|
2025
|
Invention
|
Targeted dynamic antimicrobial systems. The invention relates to a molecular system comprising: (... |
|
|
Invention
|
Immune-cell targeted bispecific chimeric proteins and uses thereof.
The present invention relate... |
|
|
Invention
|
Cd20 binding single domain antibodies.
The present application relates, in part, to agents that ... |
|
|
Invention
|
Targeted mutant interferon-gamma and uses thereof.
The present invention relates, in part, to ch... |
|
|
Invention
|
Fthl17 immunogen and tcr. The invenon relates to immunogenic pepdes, HLA-immunogenic pepde comple... |
|
|
Invention
|
Targeted mutant interferon-beta and uses thereof.
The present invention relates, in part, to chi... |
|
|
Invention
|
C1q as target to treat fatigue. The present invention relates to compounds which are capable to b... |
|
|
Invention
|
Use of azathioprine for the treatment of cysts. The invention relates to purine synthesis inhibit... |
|
|
Invention
|
Means and methods for spraying microdroplets from a chip. The present invention relates to the fi... |
|
|
Invention
|
Compositions for improving taste. The present invention relates to a composition for improving ta... |
|
|
Invention
|
Clec9a binding agents.
The present invention relates, in part, to agents that bind Clec9A and th... |
|
|
Invention
|
Short stature corn plants. The present invention discloses modified corn plants which have been e... |
|
|
Invention
|
Genetic risk factors for atypical frontotemporal lobar degeneration with ubiquitin inclusions. Th... |
|
|
Invention
|
Pore monomers and their uses. The present invention relates to novel pore monomers which have bee... |
|
|
Invention
|
Yeast for increased lipid production. The present invention relates to a recombinant oleaginous y... |
|
|
Invention
|
Novel plant growth promoting bradyrhizobium compositions. BradyrhizobiumBradyrhizobium bacterium ... |
|
|
P/S
|
Pharmaceutical preparations; Medicinal healthcare preparations; drugs for medical purposes; Diagn... |
|
|
Invention
|
Protein nanofibrils as coformulant. The present invention relates to the field of protein nanofib... |
|
|
Invention
|
Interleukine-2 muteins with enhanced specificity towards treg cells and improved production capac... |
|
|
Invention
|
Interleukine-2 muteins with enhanced specificity towards cd8+ t cells and improved production cap... |
|
|
Invention
|
Oligonucleotides for modulating synaptogyrin-3 expression. The invention relates to an oligonucle... |
|
|
Invention
|
Means and methods for single molecule peptide sequencing.
The present invention relates to the f... |
|
|
Invention
|
Modulation of dendritic cell lineages.
The present invention relates, in part, to agents, chimer... |
|
|
Invention
|
Fusokines involving cytokines with strongly reduced receptor binding affinities.
The present inv... |
|
|
Invention
|
Allosteric modulators of inhibitory immune receptor complexes. This disclosure relates to an immu... |
|
|
Invention
|
Binders of the pd-1•pd-l1 complex and their use. This disclosure relates to an immunoglobulin sin... |
|
|
Invention
|
Morphoregulators for maize transformation. Morphoregulator polypeptides that can be used to impro... |
|
|
Invention
|
Cd8 binding agents.
The present invention relates, in part, to agents that bind CD8 and their us... |
|
|
Invention
|
Cell killing monitoring system. A system for monitoring effector cell mediated killing of target ... |
|
|
Invention
|
Therapeutic and diagnostic applications of elongation of very long chain fatty acids protein 1. T... |
|
|
Invention
|
Yeast for increased lipid production. Yarrowia lipolytica Y. lipolyticaY. lipolyticaY. lipolytica... |
|
|
Invention
|
De novo design of antibodies targeting a specific epitope. The present invention relates to metho... |
|
|
Invention
|
Mutant csgg pores.
The invention relates to mutant forms of CsgG. The invention also related to ... |
|
|
Invention
|
Targeted modified tnf family members.
The present invention relates to a modified cytokine of th... |
|
2024
|
P/S
|
Science and technology services, namely, scientific and technological research in the field of ph... |
|
|
P/S
|
Pharmaceutical preparations and substances, namely, pharmaceutical preparations for the treatment... |
|
2023
|
Invention
|
Computer-implemented means and methods for the prediction of the stability of proteins and protei... |
|
|
Invention
|
Method of determining loss of heterozygosity status of a tumor.
This disclosure relates to metho... |
|
|
Invention
|
Metal-binding bacterial protein fibers.
The present invention relates to the field of bacterial ... |
|
|
Invention
|
New loxpsym sites for large-scale orthogonal cre-mediated recombination.
The invention relates t... |
|
|
Invention
|
Antivirals against human parainfluenza virus.
The invention relates to antigen-binding protein a... |
|
|
Invention
|
Inhibition of tcf4/itf2 in the treatment of cancer.
The invention relates to the application of ... |
|
|
Invention
|
Binding molecules targeting il-12rb2.
The present invention provides binding molecules, particul... |
|
|
Invention
|
Antisense oligonucleotides for treating a disease or condition associated with an abnormal proces... |
|
|
Invention
|
Improved microfluidic chip, system and method for protein purification.
The current invention re... |
|
|
P/S
|
Pharmaceutical, medical and veterinary preparations and substances; diagnostics and therapeutic p... |
|
|
Invention
|
Optimized base editors.
The present invention relates to an adenine base editor (ABE), and compo... |
|
2022
|
P/S
|
Pharmaceutical preparations and substances, namely, biotherapeutics for targeted protein degradat... |
|
|
Invention
|
Methods for isolation of lipid-disc compositions and uses thereof.
The invention relates to the ... |
|
|
Invention
|
Glyco-engineered yeast for therapeutic protein production.
The invention relates to the field of... |
|
2020
|
P/S
|
Proteins for use in drug discovery and structural biology, namely, proteins, protein conjugates, ... |
|
|
P/S
|
Pharmaceutical and veterinary products. Scientific and technological services and research and
d... |
|
2019
|
P/S
|
Medical and veterinary preparations and articles; diagnostic preparations and materials; pharmace... |
|
|
P/S
|
Pharmaceuticals and natural remedies; Medicines for veterinary purposes; Pharmaceutical preparati... |
|
|
Invention
|
Fibroblast binding agents and use thereof. The present invention relates, in part, to agents that... |
|
2010
|
P/S
|
Research and development in the field of neuroscience and neuroelectronics |
|
|
P/S
|
Research and development in the field of neuroscience and
neuroelectronics. |
